Abstract
Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Keywords: apoptosis, baculovirus, caspases, caspase independent
Current Genomics
Title: The p35 Family of Apoptosis Inhibitors
Volume: 5 Issue: 3
Author(s): A. M. Jabbour and C. J. Hawkins
Affiliation:
Keywords: apoptosis, baculovirus, caspases, caspase independent
Abstract: Cells often respond to viral infection by activating a cellular suicide process, limiting viral replicative potential and hence minimising the spread of the infection. This cellular self-destruction, termed apoptosis, occurs in a tightly regulated, morphologically and biochemically defined manner. To counter this host response to infection, some viruses have evolved molecular strategies to evade apoptosis by encoding proteins that inhibit components of the hosts apoptotic machinery. The first identified member of the p35 family, encoded by an insect virus genome, was cloned by virtue of its ability to inhibit insect cell death induced by viral infection. Many insect viruses carry p35 genes and numerous studies have indicated that p35 proteins can suppress a wide variety of cell death stimuli in cells of evolutionarily divergent organisms. A second member of the p35 family, p49, has also recently been cloned and characterised. Like p35, p49 was originally isolated as an inhibitor of infection mediated insect cell death but can also suppress other apoptotic stimuli. Members of the p35 family suppress apoptosis by inhibiting caspases, a family of cysteine proteases that constitute the effector arm of cell death pathways, through a substrate-inhibitor mechanism. This article reviews the anti-apoptotic capacities of members of the p35 family and the mechanism of action underlying their pro-survival activity. Insights into the molecular regulation of apoptosis gained through experimental approaches exploiting p35 family members are also discussed.
Export Options
About this article
Cite this article as:
Jabbour M. A. and Hawkins J. C., The p35 Family of Apoptosis Inhibitors, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349417
DOI https://dx.doi.org/10.2174/1389202043349417 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Impact of Drug Metabolism/Pharmacokinetics and their Relevance Upon Traditional Medicine-based Cardiovascular Drug Research
Current Drug Metabolism Role of NF-κB in the Regulation of Cytochrome P450 Enzymes
Current Drug Metabolism Predominant Expression of rTERTb, an Inactive TERT Variant, in the Adult Rat Brain
Protein & Peptide Letters Synthetic Curcumin Analog UBS109 Inhibits the Growth of Head and Neck Squamous Cell Carcinoma Xenografts
Current Cancer Drug Targets Overview and Developments Regarding Functional Foods and Beverages
Current Nutrition & Food Science microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Current Pharmaceutical Design A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Review of Olmesartan Medoxomil in Achieving Guideline-Recommended Target BP Goals and Implications for Managed Care
Current Hypertension Reviews Insights Into the Role of microRNAs in Cardiac Diseases: From Biological Signalling to Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry Current Status of CETP Inhibitors in the Treatment of Hyperlipidemia: An Update
Current Clinical Pharmacology Interrupting the Natural History of Diabetes Mellitus: Lifestyle, Pharmacological and Surgical Strategies Targeting Disease Progression
Current Vascular Pharmacology Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
Current Drug Targets Nitric Oxide Synthase Function in Exercise
Current Enzyme Inhibition New Hybrid Method for Left Ventricular Ejection Fraction Assessment from Radionuclide Ventriculography Images
Current Medical Imaging Oxidative Stress, Redox Signaling and Cancer Chemoresistance: Putting Together the Pieces of the Puzzle
Current Medicinal Chemistry Endoplasmic Reticulum Stress Inhibition Enhances Liver Tolerance to Ischemia/Reperfusion
Current Medicinal Chemistry Cell Adhesion Molecules as Pharmaceutical Target in Atherosclerosis
Mini-Reviews in Medicinal Chemistry Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review
Current Vascular Pharmacology Advances in Stem Cells Transplantation for the Therapy of Parkinson’s Disease
Current Stem Cell Research & Therapy Targeting Nrf2 in Protection Against Renal Disease
Current Medicinal Chemistry